Adams Agnieszka, Pandeya Nirmala, De'Ambrosis Brian, Plasmeijer Elsemieke, Panizza Ben, Green Adele C, Olsen Catherine M, Whiteman David C
Faculty of Medicine, The University of Queensland, St Lucia, Queensland, Australia.
QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
Australas J Dermatol. 2020 Aug;61(3):e303-e309. doi: 10.1111/ajd.13247. Epub 2020 Feb 3.
BACKGROUND/OBJECTIVES: Basal cell carcinomas (BCCs) and cutaneous squamous cell carcinomas (SCCs) are the most commonly encountered cancers in fair-skinned populations worldwide. Perineural invasion is associated with worse outcomes for patients with BCC or SCC. Estimates of perineural invasion prevalence range widely, likely reflecting non-representative patient samples. We sought to determine the prevalence of perineural invasion in BCC and SCC in the general population, as well as among cancers arising in solid organ transplant recipients.
We retrospectively analysed histopathology reports of BCC and SCC from patients enrolled in the QSkin Study (a population-based cohort of 43 794 Queensland residents recruited 2010-2011) and the Skin Tumours in Allograft Recipients (STAR) study (a cohort of 509 high-risk kidney or liver transplant recipients at the Princess Alexandra Hospital, Brisbane, recruited 2012-2014.) We estimated the prevalence of perineural invasion (and 95% confidence interval) in BCC and SCC, respectively, and identified clinical factors associated with perineural invasion.
In QSkin, we observed 35 instances of perineural invasion in 9850 histopathologically confirmed BCCs (0.36%) and 9 instances of perineural invasion in 3982 confirmed SCC (0.23%) lesions. In the STAR cohort, we identified 4 lesions with perineural invasion in 692 BCCs (0.58%) and 16 reports of perineural invasion in 875 SCC lesions (1.9%).
These data suggest that the overall prevalence of perineural invasion in keratinocyte cancer is low, although perineural invasion prevalence may be slightly higher among organ transplant recipients when compared to the general population.
背景/目的:基底细胞癌(BCC)和皮肤鳞状细胞癌(SCC)是全球白种人群中最常见的癌症。神经周围浸润与BCC或SCC患者的不良预后相关。神经周围浸润患病率的估计范围差异很大,这可能反映了患者样本缺乏代表性。我们试图确定普通人群中BCC和SCC以及实体器官移植受者发生的癌症中神经周围浸润的患病率。
我们回顾性分析了参与QSkin研究(2010 - 2011年招募的43794名昆士兰居民的基于人群的队列)和移植受者皮肤肿瘤(STAR)研究(2012 - 2014年在布里斯班亚历山德拉公主医院招募的509名高危肾或肝移植受者队列)的患者的BCC和SCC组织病理学报告。我们分别估计了BCC和SCC中神经周围浸润的患病率(以及95%置信区间),并确定了与神经周围浸润相关的临床因素。
在QSkin研究中,我们在9850例经组织病理学确诊的BCC中观察到35例神经周围浸润(0.36%),在3982例确诊的SCC病变中观察到9例神经周围浸润(0.23%)。在STAR队列中,我们在692例BCC中发现4例有神经周围浸润(0.58%),在875例SCC病变中有16例神经周围浸润报告(1.9%)。
这些数据表明,角质形成细胞癌中神经周围浸润的总体患病率较低,尽管与普通人群相比,器官移植受者中神经周围浸润的患病率可能略高。